GlaxoSmithKline Award Lecture. The O-GlcNAc modification: three-dimensional structure, enzymology and the development of selective inhibitors to probe disease. (2010)
Attributed to:
Studies of the O-GlcNAc Modification
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bst0381179
PubMed Identifier: 20863281
Publication URI: http://europepmc.org/abstract/MED/20863281
Type: Journal Article/Review
Volume: 38
Parent Publication: Biochemical Society transactions
Issue: 5
ISSN: 0300-5127